Salbiya, Loida .
HRN: 27-35-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CEFUROXIME 500MG (TAB)
06/21/2025
06/28/2025
PO
1 Tab
BID
SP NSVD W RMLE
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines